Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,673 | 8,989 | 6,344 | 3,851 | 2,988 |
| Marketable Securities | N/A | 67 | 133 | 149 | 241 |
| Receivables | 2,752 | 1,598 | 1,829 | 2,728 | 2,512 |
| TOTAL | $12,425 | $10,654 | $8,306 | $6,728 | $5,741 |
| Non-Current Assets | |||||
| PPE Net | 619 | 378 | 329 | 415 | 1,422 |
| TOTAL | $619 | $378 | $329 | $415 | $1,422 |
| Total Assets | $30,443 | $25,638 | $24,981 | $21,660 | $24,796 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $266 | $268 | $363 | $765 | $1,503 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,275 | 5,888 |
| Other Non-Current Liabilities | 1 | 0 | 384 | 124 | 111 |
| TOTAL | $1 | $N/A | $384 | $2,399 | $5,999 |
| Total Liabilities | $6,230 | $6,532 | $7,839 | $8,993 | $11,544 |
| Shareholders' Equity | |||||
| Retained earnings | 13,948 | 12,314 | 9,515 | 8,310 | 8,888 |
| Other shareholders' equity | 10,265 | 6,792 | 7,627 | 4,357 | 4,364 |
| TOTAL | $24,213 | $19,106 | $17,142 | $12,667 | $13,252 |
| Total Liabilities And Equity | $30,443 | $25,638 | $24,981 | $21,660 | $24,796 |